The interactions between cancer cells and their microenvironment are crucial for malignant progression, as they modulate invasion-related activities. Tumor-associated macrophages are generally considered allies in the process of tumor progression in several types of cancer, although their role on gastric and colorectal carcinomas is still poorly understood. In this report, we studied the influence of primary human macrophages on gastric and colorectal cancer cells, considering invasion, motility/migration, proteolysis and activated intracellular signaling pathways. We demonstrated that macrophages stimulate cancer cell invasion, motility and migration, and that these effects depend on matrix metalloproteinase (MMP) activity and on the activation of epidermal growth factor receptor (EGFR) (at the residue Y 1086 ), PLC-g (phospholipase C-gamma) and Gab1 (GRB2-associated binding protein-1), as evidenced by siRNA (small interference RNA) experiments. Epidermal growth factor (EGF)-immunodepletion impaired macrophage-mediated cancer cell invasion and motility, suggesting that EGF is the pro-invasive and pro-motile factor produced by macrophages. Macrophages also induced gastric and colorectal cancer cell phosphorylation of Akt, c-Src and ERK1/2, and led to an increase of RhoA and Cdc42 activity. Interestingly, whereas macrophage-mediated cancer cell c-Src and ERK1/2 phosphorylation occurred downstream EGFR activation, Akt phosphorylation seems to be a parallel event, taking place in an EGFRindependent manner. The involvement of EGF, EGFR-downstream signaling partners and MMPs in macrophage-mediated invasion provides novel insights into the molecular crosstalk established between cancer cells and macrophages, opening new perspectives for the design of new and more efficient therapeutic strategies to counteract cancer cell invasion.
INTRODUCTION
Cancer cell invasion and metastasis are paramount events in malignant progression. In the last decade, several authors have described interactions between cancer cells and several elements of the tumor microenvironment, such as extracellular matrix (ECM), fibroblasts, endothelial and bone marrow cells, as being responsible for triggering and modulating invasion-associated activities, namely proteolysis, angiogenesis and motility. [1] [2] [3] [4] [5] [6] [7] Over the last decade, a strong association between cancer progression and inflammation has emerged. 1, [8] [9] [10] The presence of immune cells at the tumor site can result from a previous chronic inflammation that triggered tumourigenesis, or as a response to tumor growth and subsequent tissue disruption. 3 Immune cells may contribute to cancer development through the release of soluble mediators, regulating cell proliferation, migration, angiogenesis, tissue remodeling and metabolism. 1, 3, 9, 10 Tumor-associated macrophages (TAMs) constitute, in many tumors, the major inflammatory cellular component of the stroma. 3 They differentiate from circulating monocytic precursors attracted to injured tissues, and change their molecular profile, acquiring new functions in response to stimuli found temporarily at the tissue microenvironment. TAMs can also be found at highly vascularized regions in the neighborhood of invasive tumor cells. [11] [12] [13] Upon activation by cancer cells, TAMs produce and release a diversity of growth factors, proteolytic enzymes, cytokines and other inflammatory mediators that may have an important role in cancer progression and metastasis. 3, 14 In melanoma and breast cancer, macrophages are found at areas of basement membrane degradation or at the invasive front of more advanced tumors, 15, 16 and their importance for tumor progression and metastasis is well documented. [14] [15] [16] [17] [18] A paracrine loop involving the production of colony-stimulating factor-1 (CSF-1) by breast cancer cells and of epidermal growth factor (EGF) by macrophages has been reported to modulate ECM remodeling and intravasation of cancer cells into neighbor blood vessels. 15 Despite the continuously growing body of knowledge, the role of macrophages within colorectal and gastric tumor microenvironment remains still unclear and controversial. While some studies point to a survival benefit provided by TAMs, 12 the majority suggest that they might promote tumor progression. [20] [21] [22] [23] In a recent study, the number of intratumoral TAMs not only correlated with the depth of colorectal cancer invasion, lymph node metastasis and tumor staging, but also with matrix Figure 1 . Macrophages stimulate gastric cancer cell invasion through the production of paracrine factor(s). Stimulation of invasion is sensitive to tyrosine kinase and MMP inhibitors. (a) The preparation of CM and Matrigel two-compartment invasion assays is schematically represented. In the subsequent panels, AGS human gastric cancer cells were incubated for 24 h in the upper compartment of Matrigel invasion chambers, in the presence of: (b) RPMI medium ( À ) or human macrophages (Mac) differentiated during 1, 7 or 13 days; (c) RPMI medium ( À ), human macrophages differentiated for 13 days (Mac), or CM of: RPMI (CMMatRPMI), macrophages (CMMatMac), AGS and macrophages previously cocultured in invasion assays (CMMat(AGS þ Mac)), or AGS and macrophages without previous contact (CMMatAGS metalloproteinases (MMP)-2 and MMP-9 expression levels. 24 The same study revealed that when cocultured with macrophages, colorectal cancer cells increased their invasion, migration and MMPs secretion level, suggesting intratumour TAMs as a progressive marker for colorectal cancer. 24 Monocyte chemoattractant protein-1 produced by gastric tumor cells also mediates the recruitment of macrophages, and has been associated with malignant behavior, including tumor invasion, lymphatic infiltration and angiogenesis. 22, 25 Activated macrophages are also described to produce tumor necrosis factor-a, promoting gastric tumor cell Wnt signaling, 26 and possibly contributing to tumor development by regulation of cell growth, differentiation and survival.
In the present study, we clarified the role of primary human macrophages on gastric and colorectal cancer cell invasion, and dissected the associated molecular mechanisms. Our results demonstrated that macrophages promote gastric and colorectal cancer cell invasion, motility and migration. EGF immunodepletion impairing macrophage-mediated cancer cell invasion and motility suggested EGF as the pro-invasive and pro-motile factor produced by macrophages. Further, we reported that macrophage-mediated invasion is preceded by membrane recruitment and phosphorylation of cancer cell epidermal growth factor receptor (EGFR), and we identified the target receptor-phosphorylation site (Y 1086 ) and the underlying signaling pathways. The involvement of Gab1 and PLC-g, the phosphorylation of c-Src, ERK1/2 and Akt, and the activation of the smallGTPases, Cdc42 and RhoA, are described.
This study demonstrates that non-invasive gastrointestinal cancer cells modify their behavior and signaling in the presence of macrophages. These data contribute to clarify the role of the tumor microenvironment on the activation of invasion but, more importantly, introduce macrophages as a cellular promoter of invasion in gastrointestinal cancer, opening new possibilities for therapeutic patient stratification.
RESULTS

Macrophages stimulate gastric cancer cell invasion
To assess the role of macrophages on gastric cancer cell invasion, Matrigel invasion assays confronting non-invasive AGS cells with primary human macrophages, differentiated from healthy blood donor monocytes, were performed ( Figure 1a) . For control purposes, each cell population was also cultured alone and the effect of soluble mediators produced by single-cell macrophage cultures was also tested (Figure 1a) . The presence of macrophages significantly stimulated the number of AGS cells able to invade Matrigel-coated filters (Figure 1b) . Stimulation of invasion occurred through the action of one or more soluble factors, as in this experimental setting no direct contact between the two cell types was established. The number of invasive cells was related to the time of macrophage differentiation since macrophages cultured for 13 days, on the lower compartment of the invasion chambers, provided a higher stimulus than those differentiated for 1 or 7 days (Figure 1b) . For this reason, all subsequent experiments were performed with macrophages differentiated for 13 days. The influence of soluble factors' concentration, released into the medium during macrophage differentiation, was excluded by media exchange prior to the invasion assays.
To investigate whether stimulation of invasion required the establishment of a paracrine loop, conditioned media (CM) from macrophages (CMMatMac), macrophages and cancer cells previously cocultured during invasion assays (CMMat(AGS þ Mac)) or macrophages and cancer cells without previous contact (CMMatAGS þ CMMatMac) were added to AGS cells in the absence of macrophages. Although this experimental set-up evidenced that both CMMatMac and CMMat(AGS þ Mac) were able to stimulate cancer cell invasion, CM prepared in the presence of macrophages and cancer cells (CMMat(AGS þ Mac) revealed to be the most efficient (Figure 1c) . Importantly, both CM were not as stimulatory as macrophage themselves, suggesting that maximum stimulation of invasion requires the Figure 2 . MMP-9 activity is higher in macrophages and enhances significantly when gastric cancer cells are cocultured with macrophages. (a) Conditioned media from Matrigel invasion assays containing only RPMI (CMMatRPMI), AGS (CMMatAGS), macrophages (CMMatMac) or AGS and macrophages (CMMat(AGS þ Mac)) were run on gelatin zymograms. Proteolytic bands were revealed in white on a Coomassie Blue-stained background. Densitometry analysis using the QuantityOne software (Bio-Rad) allowed quantification of pro-MMP-9 and MMP-9 (b), and pro-MMP-2 and MMP-2 activity (c). Percentage (%) of macrophage (CMMatMac), AGS cells (CMMatAGS) and cocultures (CMMat(AGS þ Mac)) proteolytic activity was compared with the activity present in RPMI culture medium (CMMatRPMI). Data correspond to mean values of independent experiments performed with macrophages from at least four different donors. Flags indicate s.e.m. *, significantly different from CMMatRPMI at Po0.05; **, significantly different at Po0.05. presence of both cell types. This is reinforced by the observation that CM from both cellular components without previous contact (CMMatMac þ CMMatAGS) do not result in stimulation of cancer cell invasion. Altogether, these results evoke the existence of a paracrine loop established between macrophages and cancer cells.
To investigate the involvement of known invasion-associated molecules on macrophage-mediated cancer cell invasion, small inhibitory molecules targeting EGFR (IRESSA also named ZD1839 or Tyrphostin AG1478), phosphatidylinositol 3-kinase (PI3K) (LY294002), Rho-associated protein kinase (ROCK) (Y27632) or MMPs (Galardin) were tested in invasion assays, confronting both cancer cells and macrophages. Our results suggest EGFR, MMPs and PI3K, but not ROCK, as important factors in this crosstalk, as stimulation of invasion was sensitive or not to the action of the respective inhibitors (Figure 1d ). The participation of tyrosine kinases, other than EGFR, however, could not be excluded.
Macrophages and gastric cancer cell cocultures exhibit higher MMP-2 and MMP-9 activity Proteolysis is an important process for cancer cell invasion, being generally mediated through the action of MMPs.
1 Considering our previous results with galardin, suggesting a role for MMPs in the macrophage-mediated gastric cancer cell invasion, the proteolytic activity of invasion-derived CM was evaluated by gelatin zymography (Figure 2a ). Our results confirmed that macrophages cultured with ECM components (Matrigel) (CMMatMac) exhibit high MMP-9 proteolytic activity, unlike AGS cells (CMMatAGS). Additionally, in supernatants of invasion assays with AGS and macrophages (CMMat(AGS þ Mac)), pro-and active MMP-9 activity was significantly enhanced when compared with supernatants from AGS cells alone (CMMatAGS) (Figure 2b ). Pro-MMP-2 values were generally lower than those of pro-MMP-9. Enhanced pro-MMP-2 activity was found on macrophage-conditioned medium (CMMatMac) and when cancer cells were cocultured with macrophages (CMMat(AGS þ Mac)) ( Figure 2c ).
Macrophages stimulate gastric cancer cell motility and migration In order to evaluate the effect of macrophages on cancer cell motility and actin/tubulin cytoskeleton organization, F-actin and a-tubulin stainings were performed. Within 6 h of CMMac addition, cancer cell morphology changed, losing the strong actin-belt present at the cell periphery and acquiring motility structures such as filopodia and lamellipodia (Figure 3a , right panel, white arrows). Although no major alterations were observed in the pattern of tubulin distribution, our results suggest a rapid actin cytoskeleton assembly and turnover, characteristic of moving cells. 27, 28 Additionally, macrophage-conditioned cancer cells presented reduced stress fibers and a more elongated phenotype, suggesting enhanced migration.
To investigate the dynamics of cell morphology variations, trajectories' shape, velocity and distance migrated, time-lapse video microscopy was performed for 13 h upon the treatment of AGS cells with CMMac. In the presence of RPMI-conditioned media (CMRPMI), AGS cell trajectories were short and circumscribed to ) tyrosine phosphorylation Our results demonstrated that specific EGFR inhibitors (Iressa and Tyrphostin AG1478) counteract macrophage-mediated invasion, suggesting that this receptor and its downstream signaling pathways might be stimulated by macrophages. Previous studies, reporting EGF involvement in macrophage-breast cancer cell crosstalk, 16, 18, 29 prompted us to evaluate the effect of macrophages on gastric cancer cell EGFR tyrosine phosphorylation. We observed that 15 min upon incubation with CMMac, the endogenous phosphorylation level of the EGFR Y 1086 residue increased and its distribution pattern was altered, accumulating preferably at the cell periphery (Figure 3d ). After 1 h of incubation, this effect was more pronounced and the receptor displayed a radial distribution at the cell membrane, accompanied by filopodia-like structures. However, 6 h after treatment, this effect was no longer observed (data not shown). Altogether, these results show that CMMac modifies the phosphorylation status of EGFR, leading to receptor-localized clustering, mostly at filopodia-like structures.
EGFR, PLC-g and Gab1 are required for macrophage-mediated gastric cancer cell invasion and migration Aiming at the understanding of the involvement of EGFR and related signaling pathways on the process of macrophagemediated invasion, we transiently transfected AGS cells with siRNA abrogating the expression of EGFR and of some downstream interacting partners, such as PLC-g, Gab1, Cbl and FAK. Silencing of these molecules was maximal 48 h after transfection, as confirmed by immunoblotting analysis (Figure 4a ). Therefore, Matrigel invasion assays confronting silenced AGS cells with macrophages were initiated 24 h after transfection. A significant decrease in invasion was detected when EGFR and PLC-g were transiently silenced, suggesting that they are required for macrophage-mediated cancer cell invasion ( Figure 4b ). As these molecules are often related to cell motility and actin cytoskeleton rearrangements, 30, 31 we evaluated their relevance for macrophage-mediated cancer cell migration and motility. Consequently, time-lapse microscopy studies on AGS cells with silenced EGFR, PLC-g, Gab1, Cbl and FAK expression were performed 24 h after transfection in the presence of CMMac or CMRPMI. EGFR, Gab1 and, to a lower extent, PLC-g seem to be required for macrophage-mediated cell migration, as their reduced expression significantly affected the distance migrated (Figure 4c ). Altogether, these results evidence that EGFR and EGF immunodepletion impairs macrophage-mediated cancer cell invasion and motility Aiming to elucidate whether macrophage-mediated effect on cancer cell invasion and motility was EGF-dependent, as previously suggested by our and others' results, 16, 18, 29 immunodepletion experiments were performed using anti-EGF antibody and the isotype-matched immunoglobulin (IgGs), as control. After this procedure, an B15-kDa band, recognized by the anti-EGF antibody and absent in the isotype-matched-IgG control, was detected in the immunoprecipitated (Figure 5a Macrophages also stimulate colorectal cancer cell invasion, and EGFR, Akt, c-Src and ERK phosphorylation The effect of macrophages on the invasion ability of other gastric and colorectal cancer cells has also been explored (Supplementary Table I ). To investigate whether the same signaling pathways are similarly regulating the effect of macrophages on colorectal cancer cell invasion, we used the same experimental set-up as for gastric cancer cells described above. Our results demonstrated that soluble factors, present in CMMac, stimulate RKO cell invasion through Matrigel-coated filters (Figure 7a ). Such stimulation seems to occur downstream EGFR activation, as siRNA targeting this receptor expression counteracted colorectal cancer cell invasion (Figure 7a) (Figures 7b and c) on both cell lines. These results indicate that macrophage-mediated cancer cell c-Src and ERK1/2 phosphorylation occur downstream EGFR activation, whereas Akt phosphorylation seems to be a parallel event taking place in an EGFR-independent manner.
DISCUSSION
In this study, we demonstrated that human primary macrophages stimulate gastric and colorectal cancer cell motility, migration and invasion, and showed that stimulation of these cellular activities is preceded by membrane accumulation and phosphorylation of EGFR at the tyrosine residue Y
1086
. Additionally, we demonstrated that EGF is a key pro-invasive and pro-motile factor produced by macrophage, and elucidated that the underlying signaling pathway requires Gab1 and PLC-g, phosphorylation of c-Src, ERK1/2 and Akt, and activation of the smallGTPases, Cdc42 and RhoA. In addition, we demonstrated that while macrophage-mediated c-Src and ERK1/2 phosphorylation occur downstream EGFR, Akt phosphorylation seems to take place in an EGFR-independent manner. This is the first time, to the best of our knowledge, that macrophage-mediated gastric and colorectal cancer cell invasion is described to involve EGF, to require EGFR phosphorylation and to identify the receptor phosphorylated tyrosine residues and associated downstream molecules. Our study defines potential therapeutic targets to prevent macrophage-mediated gastric/ colorectal cancer invasion, and reinforces the pro-invasive role of macrophages. . Phosphorylated levels of PLC-g were analyzed by immunoblotting after immunoprecipitation with PY-20, an antibody recognizing tyrosine-phosphorylated residues. (b) Cell lysates were also submitted to smallGTPases pull-down assays, using the GST-C21 Rhotekin for RhoA or the GST-PAK 167 ± 150 for Cdc42 and Rac1, precoupled to glutathione-sepharose beads. Activated GTPases bound to the GST-fusion proteins were eluted with sample buffer and resolved by SDS±PAGE. Immunoblots for total GTPases confirmed that equal amounts of proteins were used in the pulldowns. These images are representative of independent experiments performed with CM of macrophages from at least three different donors.
In breast tumors, in vitro and in vivo studies revealed macrophages as obligate partners for cancer cell migration, invasion and metastasis. 14, 32, 33 In gastrointestinal tumors, data regarding the participation of macrophages in these cellular activities are scarce and the underlying molecular pathways remain to be dissected. 34 Our results demonstrate that macrophages stimulate invasion of gastric and colorectal cancer cells through a mechanism that does not require direct cell contact but the release into the medium of soluble pro-invasive factors namely EGF. A paracrine loop between macrophages and cancer cells seems to be established, as maximum stimulation was achieved when both cells were present. For breast cancer, a paracrine loop involving the production of CSF-1 by cancer cells and of EGF by macrophages has been reported. 16, 18, 29 Disruption of this loop by blockade of either EGF receptor or CSF-1 receptor signaling was sufficient to inhibit both macrophage, and tumor cell migration and invasion. 29 More recently, resident macrophages of the brain were shown to induce glioblastoma cell invasion through the EGFR/CSF-1R signaling. 35 In the present study, we aimed at identifying the pro-invasive and pro-motile factor, and dissecting the associated signaling pathways.
ECM degradation by proteolytic enzymes facilitates motility and invasion by opening paths to migrating cells and by assisting the release of pro-motile/pro-invasive peptides entrapped within the matrix.
6,27,36-38 MMP-increased expression and activity have been positively correlated with tumor progression in several types of cancer. 37, 38 In our model, we found that macrophage-mediated invasion is sensitive to MMP inhibition, and confirmed macrophages as high producers of MMP-2 and MMP-9 proteases. 36, 39 These data suggest macrophages as the major contributors of the enhanced proteolysis found in cocultures, and reinforces MMPs as crucial factors in macrophage-mediated invasion.
Our results also demonstrate that macrophages modulate cancer cell actin cytoskeleton remodeling, leading to the formation of motility-associated structures, such as filopodia, and promoting cell migration. Previous studies revealed that macrophages exposed to cancer-cell-CM produced a truncatedfibronectin isoform and a migration-stimulating factor that promoted cancer cell migration. 40 Although we cannot rule out that a similar factor might be produced by cancer-cell-exposed macrophages, siRNA experiments and immunocytochemistry studies revealing phospho-EGFR membrane mobilization indicate that stimulation of invasion occurs through factors eliciting EGFR and Gab1 activation. Our immunodepletion experiments revealed that EGF produced by macrophages is a crucial factor in the promotion of cancer cell invasion and motility. Although with less pro-invasive and pro-motile activities, CM incubated with serotype-matched IgG was significantly promoting cancer cell invasion and motility. Still it cannot be excluded that other pro-invasive and pro-motile factors, other than EGF, may be present in CM macrophages and partially lost during the immunoprecipitation procedure.
One of our major findings was the identification of the cancer cell EGFR tyrosine residue (Y 1086 ) phosphorylated upon macrophage stimulation. EGFR was previously involved in the paracrine loop established between breast cancer cells and macrophages, and considered crucial for breast cancer migration and invasion in vitro, and for breast tumor intravasation and metastasis in vivo. 16 Our study provides additional information demonstrating that in gastric and colorectal cancer, macrophages induce EGFR membrane accumulation and receptor tyrosine phosphorylation, identifying the target amino acid residue. We demonstrated that macrophage-mediated EGFR phosphorylation occurs at Y 1086 , previously described as a Gab1 and c-Src binding site. 41, 42 Macrophage activation of cancer cell EGFR can result in downstream signaling, leading to proliferation, prevention of apoptosis, stimulation of angiogenesis, migration, invasion and metastasis. 43 In the present work, we demonstrated that downstream EGFR, PLC-g and Gab1 are also crucial for macrophage-mediated invasion. PLC-g has an important role in cytoskeleton remodeling and cell invasion, being required for EGF-induced breast cancer cell migration and metastasis, through a PI3K/Akt-dependent pathway. 44, 45 On the other hand, Gab1 is described to bind to EGFR-phosphorylated Y 1086 residue, acting as a mediator of EGF-stimulated PI3K/Akt pathway, promoting MAPK and JNK signaling. 41, 46 In the present study, we demonstrated that Gab1 is required for macrophage-mediated invasion and migration, and that ERK1/2, but not STAT3 or JNK signaling, are activated upon treatment. Previous studies revealed that macrophages stimulate breast and ovarian cancer cell invasion through the activation of NF-kB and JNK, in a tumor necrosis factor-a-dependent manner and that blockade of ERK1/2 phosphorylation did not counteract stimulation of invasion. 39 Differences between this and our work might reflect alternative mechanisms of activation of cells exposed to distinct environments. Finally, we demonstrated that EGFR expression and receptor tyrosine phosphorylation are required for c-Src and ERK1/2, but not for Akt phosphorylation. Altogether, these data suggest that macrophage-mediated Akt phosphorylation occurs in an EGFR-independent manner, and might not be related to stimulation of invasion. Our results provide consisting evidences that the EGFR-PLCg-c-Src signaling is implicated in macrophagemediated gastric and colorectal cancer invasion.
Rho GTPases have a crucial role in tumor progression, regulating cellular functions such as cell cycle, polarity, migration and cytoskeleton. 47, 48 In the present study, we demonstrated that macrophages increase both RhoA and Cdc42 activity. RhoA activity is related to stress fibers and focal adhesion formation, and has been described downstream EGFR, in E-cadherin-mutant gastric cells, to enhance motility. 49 Cdc42, on its turn, has been implicated in filopodia formation, cell polarity, 47, 48 and to cooperate with PLC-g in EGFR-derived motility. 50 Altogether, our results demonstrate that macrophages stimulate gastric and colorectal cancer cell invasion into ECM components, and that this effect is accompanied by enhanced proteolysis, cancer cell motility and migration. This is, however, to the best of our knowledge, the first time that a tyrosine residue target of macrophage-mediated-EGFR-phosphorylation is revealed and that the signaling pathways involved in macrophage promotion of gastric and colorectal cancer invasion are elucidated (Figure 8 ). These achievements provided new insights into the molecular crosstalk established between cancer cells and macrophages, opening new perspectives to the design of new and more efficient therapeutic strategies to hamper cancer cell invasion.
MATERIALS AND METHODS
Cell culture and reagents AGS, derived from a human diffuse gastric carcinoma (CRL-1739), and RKO cells, derived from a human colon carcinoma (CRL-2577), obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA), were maintained at 37 1C, 5% CO 2 humidified-atmosphere, in complete RPMI1640 medium (Invitrogen, Merelbeke, Belgium), supplemented with 10% fetal bovine serum (Lonza, Basel, Switzerland), 100 U/ml penicillin and 100 mg/ml streptomycin (Invitrogen). Pharmacological inhibitors Tyrphostin AG1478, IRESSA/ZD1839, LY294002, Galardin and Y27632 (Calbiochem, Nottingham, UK) were used at the concentrations 9.45, 1, 10, 100 and 10 mM, respectively. These concentrations were previously shown not to affect cell viability and to inhibit cell invasion induced by other stimulators, such as heregulin-b1, EGF, lithocholic acid and HGF. 6, 26 Trypan blue dye (Sigma-Aldrich, Madrid, Spain) exclusion test was used to assess cancer cell viability.
Human monocyte isolation
Human monocytes were isolated from Buffy coats from healthy blood donors, kindly provided by the Portuguese Blood Institute (IPS, Porto, Portugal), as previously described. 51 Briefly, Buffy coats were centrifuged at 1200 g, without brake, for 20 min at room temperature. Isolated cells were resuspended in complete RPMI1640 (Invitrogen), seeded in tissue-culture-Petri-dishes (Greiner, Alphen a/d Rijn, The Netherlands) at a density of 1 Â 10 7 cells/plate, and incubated for 24 h at 37 1C and 5% CO 2 . After this period, cells were transferred into tissueculture plates and differentiated during 3, 7 or 13 days in absence of M-CSF or other exogenous stimuli. Cell medium was renewed every 3 days. On average, over 80% of isolated monocytes were found to be CD14-positive (data not shown).
Matrigel invasion assays
Matrigel invasion assays have been previously useful in identifying invasion-associated signaling pathways and in dissecting cells-ECM interactions. 6, 7, 27 Briefly, Matrigel-coated inserts of 8-mm-pore size (BD Biosciences, Madrid, Spain) were placed into 24-well plates. 
Time-lapse microscopy
To track cell trajectories, 5 Â 10 4 cells/cm 2 , transfected or not with siRNAs, were seeded and allowed to adhere for 4 h at 37 1C, 5% CO 2 . Before each experiment, cells were treated with CMMac (one-third of the total volume) or equivalent CMRPMI as control. Bright field images were taken every 5 min during 13 h, using a Â 20 objective and an inverted Axiovert 200 M fluorescence microscope (CarlZeiss).
Zymography
Macrophages or invasion assays CM were analyzed by gelatin zymography. Protein content was determined by Dc Protein kit (Bio-Rad, Amadora, Portugal) and 15-20 mg of protein were mixed with sample buffer (10% sodium dodecyl sulfate, 4% sucrose and 0.03% bromophenol blue in 0.5 M Tris-HCl, pH 6.8) and separated on 10% polyacrylamide gels containing 0.1% gelatin (Sigma-Aldrich) as substrate. After electrophoresis, gels were washed twice with 2% Triton X-100. Gelatin gels were subsequently incubated for 16 h at 37 1C in 50 mM Tris-HCl, pH 7.5 and 10 mM CaCl 2 . Gels were stained with 0.1% Coomassie Brilliant Blue R-250 (Sigma-Aldrich), 50% methanol and 10% acetic acid (Merck, Algé s, Portugal). MMPs molecular weight and activity was estimated by densitometric analysis (QuantityOne, Bio-Rad).
siRNA transfection siRNAs targeting PLC-g, Gab1, Cbl and FAK, previously validated for knockdown efficiency in AGS, and two-distinct validated EGFR siRNAs were purchased from Invitrogen. Prior to transfection, 60% confluent AGS/RKO monolayers cultured on 6-well plates were incubated in serum-antibioticfree RPMI1640. Cells were transiently transfected (75 nM EGFR siRNA; 80 nM other siRNAs) using Lipofectamine2000 transfection reagent (Invitrogen). Cells transfected with only Lipofectamine2000 were used as negative control. Eight hours after transfection, medium was replaced by RPMI1640 supplemented with 10% fetal bovine serum. Knockdown efficiency was tested by western blot 48 h after transfection. 
Immunoprecipitation and western blot
Statistical analysis
Data were analyzed with Student's t-test or Mann-Whitney test (for zymograms) using GraphPad Prism v6, GraphPad Software, San Diego, CA, USA (trial version), and expressed as mean values of at least three independent experiments ( ± s.d.). Differences in data values were considered significant at a P-value of o0.05. Between the distinct assays, different donors were selected, and within each assay, at least three donors were considered, as indicated.
